Live Breaking News & Updates on Cardiocentro Ticino Foundation

Stay updated with breaking news from Cardiocentro ticino foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

No Harm in Short Aspirin Duration After PCI for ACS

Less than a month of ticagrelor plus aspirin therapy followed by ticagrelor alone for 1 year after PCI for ACS was noninferior to dual antiplatelet therapy in the T-PASS trial. ....

Soult Ukpyolsi , South Korea , Marco Valgimigli , Yonsei University College Of Medicine , Cardiocentro Ticino Foundation , Myeong Ki Hong , Yonsei University College , Transcatheter Cardiovascular Therapeutics , Acute Coronary Syndrome Acs , Cute Coronary Syndrome , Percutaneous Coronary Intervention , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Antiplatelet Agent , Clinical Research , Clinical Trials , Linical Studies , Medical Literature ,

Aspirin Still Needed in First Month After PCI: STOPDAPT-3

Using prasugrel (Effient) alone in the first month after PCI did not reduce bleeding risk and there was a suggestion of possible increased ischemic risk vs dual antiplatelet therapy, in a new trial. ....

Noord Holland , Marco Valgimigli , Masahiro Natsuaki , European Society Of Cardiology , Cardiocentro Ticino Foundation , Saga University , European Society , Erebrovascular Accident , Va Cerebrovascular Accident , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Antiplatelet Agent , Neuroendocrine Tumor , Drug Eluting Stent , Myocardial Infarction , Percutaneous Coronary Intervention ,

PANTHER: Should Clopidogrel Become the 'New Aspirin' in CAD?

The PANTHER meta-analysis of trials comparing aspirin with clopidogrel or ticagrelor as antiplatelet monotherapy in coronary artery disease patients suggest that P2Y12 inhibitor therapy is more effective. ....

France General , Comunidad Autonoma De Cataluna , Heinz Drexel , Marco Valgimigli , Steffen Massberg , Gabriel Steg , European Society Of Cardiology , University Hospital Munich , Vorarlberg Institute For Vascular Investigation , Cardiocentro Ticino Foundation , European Society , Medscape Cardiology , Vorarlberg Institute , Vascular Investigation , Seen Despite Lack , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Antiplatelet Agent , Stroke Risk , Myocardial Infarction , Percutaneous Coronary Intervention ,

Patients with coronary artery disease should receive P2Y12 inhibitor instead of aspirin

Your access to the latest cardiovascular news, science, tools and resources. ....

Comunidad Autonoma De Cataluna , Marco Valgimigli , Cardiocentro Ticino Foundation , Hot Line ,

MASTER DAPT Shows 1-month Dual Antiplatelet Therapy After Stent Benefits High Bleeding Risk Patients

MASTER DAPT Shows 1-month Dual Antiplatelet Therapy After Stent Benefits High Bleeding Risk Patients
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

Marco Valgimigli , Academic Research Consortium , European Society Of Cardiology , Cardiocentro Ticino Foundation , Hot Line , New England Journal , Bleeding Academic Research Consortium , Professor Marco Valgimigli ,